E. M. Kohner

Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 303 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Markers of Insulin Resistance Are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study

Nish Chaturvedi, A.-K. Sjoelie, Massimo Porta et al. · Diabetes Care · 2001 · 209 citations

Medicine, Ophthalmology, Diabetology +16

UK prospective study of therapies of maturity-onset diabetes

R. C. Turner, J I Mann, G. Iceton et al. · Diabetologia · 1983 · 88 citations · Full text

Medicine, Endocrinology, Internal Medicine +8

THE EFFECT OF PLASMA GLUCOSE ON THE GROWTH HORMONE RESPONSE TO HUMAN PANCREATIC GROWTH HORMONE RELEASING FACTOR IN NORMAL SUBJECTS

P. S. Sharp, Kristie L. Foley, Premjit S. Chahal et al. · Clinical Endocrinology · 1984 · 50 citations

Medicine, Endocrinology, Hormone Biochemistry +14

Continuous subcutaneous octreotide infusion markedly suppresses IGF-I levels whilst only partially suppressing GH secretion in diabetics with retinopathy

Stephen Hyer, P. S. Sharp, Roger A. Brooks et al. · European Journal of Endocrinology · 1989 · 40 citations

Medicine, Endocrinology, Pharmacology +17